Scientists Attempt Controversial Experiment to Edit DNA In Human Sperm Using CRISPR
Scientists
Attempt Controversial Experiment to Edit DNA In Human Sperm Using CRISPR
First it was human embryos. Now
scientists are trying to develop another way to modify human DNA that can be
passed on to future generations, NPR has learned.
Reproductive biologists at Weill Cornell Medicine in
New York City are attempting to use the powerful gene-editing technique called
CRISPR to alter genes in human sperm. NPR got exclusive access to watch the
controversial experiments underway.
The research is aimed at finding new ways to prevent
disorders caused by genetic mutations that are passed down from men — including
some forms of male infertility. The team is starting with a gene that can
increase the risk for breast, ovarian, prostate and other cancers.
The experiments are just starting and have not
yet been successful. But the research raises many of the same hopes — and fears
— as editing the DNA of human embryos. Nevertheless, the researchers defend the
work.
"I think it's important from the scientific point of view
to investigate in an ethical manner to be able to learn if it's possible,"
says Gianpiero Palermo, a professor of embryology in
obstetrics and gynecology at Weill Cornell Medicine, who runs the lab where the
work is being conducted.
During a recent visit to Palermo's Andrology Laboratory at Weill
Cornell's Center for Reproductive Medicine, NPR
witnessed an experiment attempting to edit a single gene in sperm.
"If we can wipe out a particular gene, it would be
incredible," Palermo says. "Theoretically, in principal, this would
be a major, major benefit to society."
Other scientists who are not
involved in the research agree. One of the main goals is to try to understand
and possibly prevent male infertility caused by genetic mutations.
"Male infertility is a very common condition," says Kyle Orwig, a professor in the department of
obstetrics, gynecology and reproductive sciences at the University of
Pittsburgh School of Medicine. "And there are some diseases that are
incredibly devastating to families. And for those diseases, for me, if you
could get rid of it, why wouldn't you get rid of it?"
But others say editing DNA in sperm raises the same troubling
questions as editing DNA in embryos. Would it ever be safe to make babies that
way? Would it open the door to someone someday trying to make "designer
babies"? Should scientists be trying to tinker with the human gene pool in
ways that could affect generations to come?
"It doesn't matter whether you're manipulating the embryo
or you're manipulating the sperm," says Françoise Baylis, a bioethicist at Dalhousie University
in Canada, who is advising the World Health Organization about gene editing.
"The concern is what kind of world are you creating as you
move down the path to start manipulating human genetics. We're on the cusp of
prospective parents controlling the genetics of their offspring," says
Baylis, who wrote the forthcoming book Altered Inheritance: CRISPR and the Ethics of Human Genome Editing.
CRISPR enables scientists to make very precise
changes in DNA. As a result, many scientists say the technique is
revolutionizing scientific research. Doctors have already started using it to
try to treat diseases, for example.
But a Chinese scientist stunned the world last year when he
announced he had used CRISPR to create the world's first genetically modified
babies — twin girls whose DNA he edited when they were embryos
to try to protect them from AIDS. The announcement was widely condemned as
premature, reckless and unethical.
In addition to concerns that such a step may be unsafe for the
resulting babies and future generations, critics say this kind of research is
unnecessary because there are other ways to prevent most genetic diseases.
Editing sperm, eggs or embryos also raises profound philosophical, moral and
ethical questions that need to be addressed first.
"There's reason to worry about undertaking the research
before we've asked the question properly whether we would ever actually want to
use those techniques," says Ben Hurlbut, a bioethicist at Arizona State University
in Tempe. "Once those techniques are developed, it becomes much harder to
govern them. If you've done the hard work of developing the recipe, someone else
can bake the cake."
Theoretically, editing DNA in human sperm could be somewhat
safer than editing DNA in human embryos, because in embryos it's possible to
inconsistently edit and miss certain cells, whereas in sperm any changes would
be present in every cell of any resulting offspring. But the larger questions
remain.
"I know that things can get dangerous and things can get
kind of out of hand quickly," says June Wang, a lab technician conducting
the experiments in New York. "But on the other hand, I think that CRISPR
can do so much. It has a lot of potential."
This particular experiment is targeting a gene known as BRCA2. Mutations in this gene can
increase the risk for breast, ovarian, prostate and other cancers.
"I have high hopes that we can have a huge impact," Wang
says.
During my tour of the facility to watch the experiment getting
underway, Wang escorts me into a small windowless research lab, after punching
a keypad on a large door.
I watch as Wang and a colleague snap
open the latches on a frosty silver canister, pop off the lid and slide out a
small vial. It contains 58 million sperm purchased by a woman for in vitro
fertilization and then donated for research after she had completed IVF.
The sperm samples are frozen in liquid nitrogen. After carefully
thawing and preparing the sperm, Wang puts millions of sperm on a
slide under a microscope to make sure they are healthy.
"It looks really good," she concludes after examining
the specimen.
The key challenge to editing DNA in human sperm is finding a way
to deliver the microscopic CRISPR gene-editing tool to the DNA. The problem is
that DNA is packed very tightly inside the head of each sperm, making it
difficult to insert the CRISPR tool. That makes many scientists wonder whether
it may even be possible.
"I think it will be very difficult to do," says David Albertini, editor of the Journal of Assisted
Reproduction and Genetics and a visiting scientist at Rockefeller University in
New York City.
Wang and Palermo acknowledge that it will be a challenge, but
they remain hopeful.
"Nobody's tried to do CRISPR on sperm before, so we have to
try to figure out the right way to do it," Wang says.
A potential solution involves a process known as electroporation, which
involves delivering an electrical shock to cells.
"The hope is that the shock will cause the sperm to kind of
loosen up a little bit for just a moment," Wang says. "When the cell
loosens up, the CRISPR gene-editing tool will hopefully get inside."
Wang carefully fills a vial with
sperm and then drips in a solution containing the CRISPR tool, which in this
case has been designed to target BRCA2. She then places the mixture inside the
electroporation machine, which will deliver an 1,100-volt shock.
"It's kind of a weird concept," Wang acknowledges. "But
it works pretty well."
After the sample is in place, Wang presses a button on the
machine, which emits a few quiet beeps.
"That is it," she says. "I just zapped all the
sperm. Hopefully the CRISPR materials got in there."
She repeats the process two more times and then places the
treated sperm samples into an incubator. In 24 hours, she will analyze the
samples for any signs the editing worked.
"I'm really hopeful we'll be able to get it. It's just
going to be a lot of work, a lot of testing and a long time, just because this
hasn't been done before," she says.
Comments
Post a Comment